Rayyan June 18, 2026 How to Master the Pharmacovigilance System Master File for Inspection Readiness Pharmacovigilance (PV) inspection outcomes are often shaped before the opening meeting begins. Inspectors typically form… Read More
Rayyan June 18, 2026 Pharmacovigilance in 2026 – What is Expected to Change in the Regulatory Landscape Across Regions? Pharma manufacturers are rapidly launching their products across borders, directly intensifying the burden on safety… Read More
Rayyan June 18, 2026 FDA Vowes Improved Adverse Event Reporting With AEMS The FDA announced today the launch of the FDA Adverse Event Monitoring System (AEMS).1 This new… Read More
Rayyan June 18, 2026 The Future of Explainable AI in Drug Safety: Building Trust and Transparency in Pharmacovigilance Introduction: The Imperative for Transparency in AI-Driven Pharmacovigilance As artificial intelligence becomes deeply embedded in… Read More
Rayyan June 17, 2026 The State of Pharma Packaging in 2026: Trends Every Packaging Leader Should Know In 2026, packaging leaders face challenges tied to patient safety, stricter regulations, and pressure for… Read More
Rayyan June 17, 2026 The ultimate guide to the Good Distribution Practices (GDP) According to the EMA, Good Distribution Practices (GDP) comprise minimum standards that a wholesale distributor must… Read More
Rayyan June 17, 2026 The Silent Shift in Pharma Supply Chains Joe Hudicka, an entrepreneur and supply chain expert, highlights what is described as a “silent… Read More